NYSE$EHC
Encompass Health Corp · Q3 2022 earnings
Q3 2022 earnings · · Investor relations
Briefing
Encompass Health's Q3 2022 performance reflected strong demand for inpatient rehabilitation services, discharge growth, and progress in reducing contract labor, but was impacted by elevated staffing costs, leading to revised 2022 guidance.
Encompass Health Corporation reported its Q3 2022 results, demonstrating strong demand for inpatient rehabilitation services with a 7.5% increase in total discharges. However, elevated staffing costs impacted profitability, leading to a revision of the company's 2022 guidance.
- Third quarter discharge growth was 7.5%, inclusive of 4.1% same-store growth.
- The company made continued progress on reducing contract labor through hiring and retention initiatives.
- Elevated staffing costs again impacted profitability.
- The company has revised its 2022 guidance.
Headline financials
Revenue & EPS history
Encompass Health · Revenue · Quarterly
$1.09B
Forward guidance
The Company is revising its guidance for full-year 2022. Net operating revenue is expected to be $4,320 to $4,350 million. Adjusted EBITDA is expected to be $800 to $820 million. Adjusted earnings per share from continuing operations attributable to Encompass Health is expected to be $2.71 to $2.86.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2022
+1.2%
Avg return
Earnings day
+1.6%
Avg return
5 days after
+2.5%
Avg return
30 days after
64%
42 / 66 earnings
Positive
+11.8%
Q1 2025
Best reaction
-9.0%
Q1 2015
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.1% | +5.0% | +6.0% | |
| Q4 2025 | +5.9% | +13.9% | +7.4% | |
| Q3 2025 | -6.9% | -6.8% | -7.5% | |
| Q1 2025 | +11.8% | +15.4% | +17.2% | |
| Q4 2024 | +1.3% | -0.6% | +0.7% | |
| Q3 2024 | +7.0% | +5.8% | +10.0% | |
| Q2 2024 | -8.7% | -7.5% | +1.0% | |
| Q1 2024 | +0.3% | +1.4% | +2.5% | |
| Q4 2023 | +1.7% | +1.9% | +5.9% | |
| Q3 2023 | -1.9% | +0.9% | +6.7% | |
| Q2 2023 | +5.0% | +6.4% | +7.6% | |
| Q1 2023 | +0.7% | -0.6% | -5.9% | |
| Q4 2022 | +1.6% | +3.1% | -9.1% | |
| Q3 2022 | +6.4% | +11.1% | +16.6% | |
| Q2 2022 | +0.6% | +4.5% | -4.0% | |
| Q1 2022 | +2.6% | +2.5% | -2.0% | |
| Q4 2021 | +1.5% | -2.9% | +8.8% | |
| Q3 2021 | -6.0% | -5.8% | -9.8% | |
| Q2 2021 | +0.7% | +3.5% | -4.1% | |
| Q1 2021 | -1.6% | -2.7% | -2.5% | |
| Q4 2020 | -3.9% | -6.2% | -6.1% | |
| Q3 2020 | -2.6% | -3.0% | +25.9% | |
| Q2 2020 | +4.5% | +3.1% | -6.4% | |
| Q1 2020 | -1.1% | -7.1% | +6.4% | |
| Q4 2019 | +0.4% | +3.1% | -2.6% | |
| Q3 2019 | -5.8% | +2.0% | +5.5% | |
| Q2 2019 | -4.0% | -7.4% | -12.6% | |
| Q1 2019 | +5.3% | +3.6% | -4.6% | |
| Q4 2018 | -4.4% | -3.5% | -13.3% | |
| Q3 2018 | -5.7% | -4.0% | +1.4% | |
| Q2 2018 | +8.8% | +5.9% | +17.4% | |
| Q1 2018 | +7.2% | +7.3% | +10.3% | |
| Q4 2017 | +3.0% | +3.9% | +7.7% | |
| Q3 2017 | +1.8% | +2.0% | +8.7% | |
| Q2 2017 | +1.9% | -0.2% | +3.6% | |
| Q1 2017 | +7.9% | +10.0% | +6.3% | |
| Q4 2016 | +0.1% | +0.5% | -1.9% | |
| Q3 2016 | +1.8% | +0.7% | +5.6% | |
| Q2 2016 | +6.7% | +3.1% | -0.3% | |
| Q1 2016 | +10.9% | — | — | |
| Q4 2015 | +9.2% | — | — | |
| Q3 2015 | -0.3% | — | — | |
| Q2 2015 | -2.9% | — | — | |
| Q1 2015 | -9.0% | — | — | |
| Q4 2014 | -4.7% | — | — | |
| Q3 2014 | -3.0% | — | — | |
| Q2 2014 | +7.4% | — | — | |
| Q1 2014 | -0.4% | — | — | |
| Q4 2013 | -2.8% | — | — | |
| Q3 2013 | +0.6% | — | — | |
| Q2 2013 | +4.7% | — | — | |
| Q1 2013 | +3.1% | — | — | |
| Q4 2012 | +7.2% | — | — | |
| Q3 2012 | +2.5% | — | — | |
| Q2 2012 | -3.7% | — | — | |
| Q1 2012 | +9.2% | — | — | |
| Q4 2010 | +3.9% | — | — | |
| Q4 2011 | +3.9% | — | — | |
| Q3 2011 | -1.0% | — | — | |
| Q2 2011 | -9.0% | — | — | |
| Q1 2010 | +0.4% | — | — | |
| Q1 2011 | +2.5% | — | — | |
| Q4 2008 | +7.8% | — | — | |
| Q3 2010 | +2.2% | — | — | |
| Q2 2010 | -1.0% | — | — | |
| Q4 2009 | -1.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro